- Home
- TPG vs MMSI Comparison
TPG vs MMSI Comparison
Compare TPG & MMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPG
- MMSI
- Stock Information
- Founded
- TPG 1992
- MMSI 1987
- Country
- TPG United States
- MMSI United States
- Employees
- TPG N/A
- MMSI N/A
- Industry
- TPG Investment Managers
- MMSI Medical/Dental Instruments
- Sector
- TPG Finance
- MMSI Health Care
- Exchange
- TPG Nasdaq
- MMSI Nasdaq
- Market Cap
- TPG 7.0B
- MMSI 5.6B
- IPO Year
- TPG 2022
- MMSI 1990
- Fundamental
- Price
- TPG $67.03
- MMSI $102.90
- Analyst Decision
- TPG Buy
- MMSI Strong Buy
- Analyst Count
- TPG 13
- MMSI 10
- Target Price
- TPG $60.75
- MMSI $107.70
- AVG Volume (30 Days)
- TPG 952.8K
- MMSI 527.1K
- Earning Date
- TPG 02-11-2025
- MMSI 02-25-2025
- Dividend Yield
- TPG 2.27%
- MMSI N/A
- EPS Growth
- TPG N/A
- MMSI 19.39
- EPS
- TPG N/A
- MMSI 2.05
- Revenue
- TPG $3,406,805,000.00
- MMSI $1,325,871,000.00
- Revenue This Year
- TPG N/A
- MMSI $9.36
- Revenue Next Year
- TPG $16.57
- MMSI $9.09
- P/E Ratio
- TPG $2,777.14
- MMSI $50.19
- Revenue Growth
- TPG 84.54
- MMSI 8.12
- 52 Week Low
- TPG $39.16
- MMSI $70.70
- 52 Week High
- TPG $72.98
- MMSI $108.08
- Technical
- Relative Strength Index (RSI)
- TPG 55.66
- MMSI 61.85
- Support Level
- TPG $61.13
- MMSI $100.22
- Resistance Level
- TPG $66.61
- MMSI $99.34
- Average True Range (ATR)
- TPG 1.74
- MMSI 1.93
- MACD
- TPG 0.34
- MMSI 0.85
- Stochastic Oscillator
- TPG 97.52
- MMSI 96.05
About TPG TPG Inc.
TPG Inc is an alternative asset firm. It invests across five multi-product platforms namely Capital, Growth, Impact, Real Estate, and Market Solutions. TPG aims to build dynamic products and options for its clients while also instituting discipline and operational excellence across the investment and performance of its portfolio.
About MMSI Merit Medical Systems Inc.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for use in interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment. The United States generates the majority of the revenue.